215 related articles for article (PubMed ID: 34748204)
1. Real World Evidence in Medical Cannabis Research.
Banerjee R; Erridge S; Salazar O; Mangal N; Couch D; Pacchetti B; Sodergren MH
Ther Innov Regul Sci; 2022 Jan; 56(1):8-14. PubMed ID: 34748204
[TBL] [Abstract][Full Text] [Related]
2. Translational hurdles with cannabis medicines.
Graham M; Lucas CJ; Schneider J; Martin JH; Hall W
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1325-1330. PubMed ID: 32281186
[TBL] [Abstract][Full Text] [Related]
3. Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeutics.
Schlag AK; O'Sullivan SE; Zafar RR; Nutt DJ
Neuropharmacology; 2021 Jun; 191():108586. PubMed ID: 33940011
[TBL] [Abstract][Full Text] [Related]
4. The value of real world evidence: The case of medical cannabis.
Schlag AK; Zafar RR; Lynskey MT; Athanasiou-Fragkouli A; Phillips LD; Nutt DJ
Front Psychiatry; 2022; 13():1027159. PubMed ID: 36405915
[TBL] [Abstract][Full Text] [Related]
5. Developing a real-world evidence base for prescribed cannabis in the United Kingdom: preliminary findings from Project Twenty21.
Sakal C; Lynskey M; Schlag AK; Nutt DJ
Psychopharmacology (Berl); 2022 May; 239(5):1147-1155. PubMed ID: 33970291
[TBL] [Abstract][Full Text] [Related]
6. Using real world evidence to optimize care: the case of medical cannabis.
Schlag AK; Nutt DJ; Lynskey M
Expert Rev Pharmacoecon Outcomes Res; 2024 Apr; 24(4):463-465. PubMed ID: 38392352
[No Abstract] [Full Text] [Related]
7. Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis Registry.
Rifkin-Zybutz R; Erridge S; Holvey C; Coomber R; Gaffney J; Lawn W; Barros D; Bhoskar U; Mwimba G; Praveen K; Symeon C; Sachdeva-Mohan S; Rucker JJ; Sodergren MH
Psychopharmacology (Berl); 2023 Aug; 240(8):1735-1745. PubMed ID: 37314478
[TBL] [Abstract][Full Text] [Related]
8. An Updated Analysis of Clinical Outcome Measures Across Patients From the UK Medical Cannabis Registry.
Ergisi M; Erridge S; Harris M; Kawka M; Nimalan D; Salazar O; Loupasaki K; Ali R; Holvey C; Coomber R; Usmani A; Sajad M; Beri S; Hoare J; Khan SA; Weatherall MW; Platt M; Rucker JJ; Sodergren MH
Cannabis Cannabinoid Res; 2023 Jun; 8(3):557-566. PubMed ID: 35073160
[No Abstract] [Full Text] [Related]
9. Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry.
Mangoo S; Erridge S; Holvey C; Coomber R; Barros DAR; Bhoskar U; Mwimba G; Praveen K; Symeon C; Sachdeva-Mohan S; Rucker JJ; Sodergren MH
Expert Rev Neurother; 2022; 22(11-12):995-1008. PubMed ID: 36573268
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome analysis of patients with multiple sclerosis - Analysis from the UK Medical Cannabis Registry.
Murphy M; Kaur V; Bui HL; Yang T; Erridge S; Holvey C; Coomber R; Rucker JJ; Weatherall MW; Sodergren MH
Mult Scler Relat Disord; 2024 Jul; 87():105665. PubMed ID: 38728958
[TBL] [Abstract][Full Text] [Related]
11. Real-World Evidence: A Primer.
Dang A
Pharmaceut Med; 2023 Jan; 37(1):25-36. PubMed ID: 36604368
[TBL] [Abstract][Full Text] [Related]
12. Understanding the Medical Chemistry of the Cannabis Plant is Critical to Guiding Real World Clinical Evidence.
Ladha KS; Ajrawat P; Yang Y; Clarke H
Molecules; 2020 Sep; 25(18):. PubMed ID: 32899678
[TBL] [Abstract][Full Text] [Related]
13. Medicinal Cannabis Guidance and Resources for Health Professionals to Inform Clinical Decision Making.
Graham M; Renaud E; Lucas CJ; Schneider J; Martin JH
Clin Ther; 2023 Jun; 45(6):527-534. PubMed ID: 37414503
[TBL] [Abstract][Full Text] [Related]
14. Real-World Evidence-Current Developments and Perspectives.
Schad F; Thronicke A
Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011793
[TBL] [Abstract][Full Text] [Related]
15. UK medical cannabis registry: assessment of clinical outcomes in patients with headache disorders.
Nicholas M; Erridge S; Bapir L; Pillai M; Dalavaye N; Holvey C; Coomber R; Rucker JJ; Weatherall MW; Sodergren MH
Expert Rev Neurother; 2023 Jan; 23(1):85-96. PubMed ID: 36722292
[TBL] [Abstract][Full Text] [Related]
16. An observational study of clinical outcome measures in patients treated with cannabis-based medicinal products on the UK Medical Cannabis Registry.
Erridge S; Leung O; Holvey C; Coomber R; Beri S; Khan S; Weatherall MW; Rucker JJ; Platt MW; Sodergren MH
Neuropsychopharmacol Rep; 2023 Dec; 43(4):616-632. PubMed ID: 38057993
[TBL] [Abstract][Full Text] [Related]
17. Real-world evidence: perspectives on challenges, value, and alignment of regulatory and national health technology assessment data collection requirements.
Sievers H; Joos A; Hiligsmann M
Int J Technol Assess Health Care; 2021 Feb; 37():e40. PubMed ID: 33622423
[TBL] [Abstract][Full Text] [Related]
18. [Real-world evidence : Benefits and limitations in multiple sclerosis research].
Ziemssen T; Rothenbacher D; Kuhle J; Berger T
Nervenarzt; 2017 Oct; 88(10):1153-1158. PubMed ID: 28776214
[TBL] [Abstract][Full Text] [Related]
19. The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia.
Webster J; Smith BD
Clin Ther; 2019 Feb; 41(2):336-349. PubMed ID: 30709609
[TBL] [Abstract][Full Text] [Related]
20. The Rise and Rise of Medicinal Cannabis, What Now? Medicinal Cannabis Prescribing in Australia 2017-2022.
Hallinan CM; Bonomo YA
Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
